Matine Charles 4
4 · Bionik Laboratories Corp. · Filed Jun 21, 2023
Insider Transaction Report
Form 4
Matine Charles
Director
Transactions
- Purchase
Common Stock, par value $0.001 per share
2023-06-09$0.60/sh+180,555$108,333→ 206,985 total
Footnotes (1)
- [F1]The reporting person acquired the shares of common stock in lieu of cash payment for $108,333 in accrued and unpaid fees relating to reporting person's services as a director of the Issuer.